CliffBio
small molecule

QUINIDINE SULFATE

QUINIDINE SULFATE

Loss of exclusivity—loss of exclusivity
CompanyCosette Pharmaceuticals →See this company's full patent-cliff portfolio

Drug detail

Brand nameQUINIDINE SULFATE
Active ingredientQUINIDINE SULFATE
Strength300MG
Dosage formTABLET, EXTENDED RELEASE
RouteORAL
ModalitySmall molecule
FDA approvalJune 1994
Marketing statusDISCN

More from Cosette Pharmaceuticals

Source: FDA Orange Book, layered on the CliffBio company graph. Cliff dates are the loss of exclusivity; estimates are projections, not legal advice.